YOUTUBE (Fox Business) - VACCINE BREAKTHROUGH: Personalized cancer treatment takes major leap
Moderna CEO Stéphane Bancel joins ‘Mornings with Maria’ to discuss the company's landmark cancer vaccine partnership with Merck. Bancel details the promising Phase 3 melanoma trial results and outlines Moderna's latest financial growth outlook. #foxbusiness #morningswithmaria 0:03 – Moderna and Merck’s Personalized Cancer Vaccine Breakthrough 1:18 – Moderna Targets FDA Approval for Next Year 2:20 – Expanding mRNA Cancer Treatment Beyond Melanoma 5:21 – Moderna’s mRNA Push: Rare Diseases and a New Flu Vaccine 7:27 – Personalized Vaccine Costs, Manufacturing and Moderna’s Growth Outlook